Océane Delandre

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Silver Nanoparticles

Plasmodium Falciparum

Health Insurance

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Océane Delandre, Ombeline Lamer, Jean-Marie Loreau, Nasserdine Papa Mze, Isabelle Fonta, Joel Mosnier, Nicolas Gomez, Emilie Javelle, Bruno Pradines
Long-Read Sequencing and De Novo Genome Assembly Pipeline of Two Plasmodium falciparum Clones ( Pf 3D7, Pf W2) Using Only the PromethION Sequencer from Oxford Nanopore Technologies without Whole-Genome Amplification. Biology 13 (2) (2024)
Océane Delandre, Ombeline Lamer, Jean-Marie Loreau, Nasserdine Papa Mze, Isabelle Fonta, Joel Mosnier, Nicolas Gomez, Emilie Javelle, Bruno Pradines
Long-Read Sequencing and De Novo Genome Assembly Pipeline of Two Plasmodium falciparum Clones ( Pf 3D7, Pf W2) Using Only the PromethION Sequencer from Oxford Nanopore Technologies without Whole-Genome Amplification. Biology 13 (2) (2024)
Océane Delandre, Ombeline Lamer, Jean-Marie Loreau, Nasserdine Papa Mze, Isabelle Fonta, Joel Mosnier, Nicolas Gomez, Emilie Javelle, Bruno Pradines
Long-Read Sequencing and De Novo Genome Assembly Pipeline of Two Plasmodium falciparum Clones ( Pf 3D7, Pf W2) Using Only the PromethION Sequencer from Oxford Nanopore Technologies without Whole-Genome Amplification. Biology 13 (2) (2024)
Océane Delandre, Mathieu Gendrot, Priscilla Jardot, Marion Le Bideau, Manon Boxberger, Céline Boschi, Isabelle Fonta, Joel Mosnier, Sébastien Hutter, Anthony Levasseur, Bernard La Scola, Bruno Pradines
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Océane Delandre, Mathieu Gendrot, Isabelle Fonta, Joel Mosnier, Nicolas Benoit, Rémy Amalvict, Nicolas Gomez, Marylin Madamet, Bruno Pradines
Prevalence of Mutations in the pfcoronin Gene and Association with Ex Vivo Susceptibility to Common Quinoline Drugs against Plasmodium falciparum. Pharmaceutics 13 (8) (2021)